← Leaderboards
George Stamatoyannopoulos
University Of Washington
$26,665,895
Attributed
$26,954,775
Total exposure
23
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.2M · FY2005–17$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$78,464,021 · 26
By mechanism
P01$41,324,102 · 7
U01$26,519,778 · 5
R01$5,804,458 · 3
R37$3,848,948 · 1
R90$369,575 · 1
T90$326,800 · 1
Top collaborators
- Thalia Papayannopoulou1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Kareen Lk Coulombe$5,261,420
- Robert Schwartz$7,397,028
- Jeremy Alan Horst$84,117
- Thalia Papayannopoulou$16,580,758
- Lynn M Riddiford$4,637,008
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyHematopoietic Stem CellsGlobinGene ExpressionLaboratory MouseHemoglobinopathiesChromatinCellsThalassemiaBaseTissue /Cell CultureProgramsHemoglobinGenetically Modified AnimalsSickle Cell AnemiaGenomicsIn VivoSeriesGenesGenomeGenetic Promoter ElementErythroidResearch PersonnelProteins
Grant awards (98)
New Chromatin Insulators and Enhancers for Gene Therapy of the Hemoglobinopathies$577,761
R01 · FY2017 · HL · contact PI
Stem Cell Gene Therapy for Hemoglobinopathies$2,336,167
P01 · FY2014 · HL · contact PI
Chromatin Insulators for Human Gene Therapy$494,139
P01 · FY2014 · HL · contact PI
Administration and Clinical Regulatory Affairs$208,859
P01 · FY2014 · HL · contact PI
Stem Cell Gene Therapy for Hemoglobinopathies$2,269,421
P01 · FY2013 · HL · contact PI
Chromatin Insulators for Human Gene Therapy$465,556
P01 · FY2013 · HL · contact PI
Administration and Clinical Regulatory Affairs$196,775
P01 · FY2013 · HL · contact PI
Stem Cell Gene Therapy for Hemoglobinopathies$2,383,844
P01 · FY2012 · HL · contact PI
Chromatin Insulators for Human Gene Therapy$492,745
P01 · FY2012 · HL · contact PI
Administration and Clinical Regulatory Affairs$208,269
P01 · FY2012 · HL · contact PI
Stem Cell Gene Therapy for Hemoglobinopathies$2,383,844
P01 · FY2011 · HL · contact PI
Chromatin Insulators for Human Gene Therapy$491,410
P01 · FY2011 · HL · contact PI
Globin Gene Switching: Molecular Control$385,008
R01 · FY2011 · DK · contact PI
Administration and Clinical Regulatory Affairs$207,706
P01 · FY2011 · HL · contact PI
Stem Cell Gene Therapy for Hemoglobinopathies$2,432,540
P01 · FY2010 · HL · contact PI
Chromatin Insulators for Human Gene Therapy$488,180
P01 · FY2010 · HL · contact PI
Globin Gene Switching: Molecular Control$388,897
R01 · FY2010 · DK · contact PI
Administration and Clinical Regulatory Affairs$206,341
P01 · FY2010 · HL · contact PI
Globin Gene Switching: Molecular Control$100,001
R01 · FY2010 · DK · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$75,659
R90 · FY2010 · HG · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$61,726
T90 · FY2010 · HG · contact PI
17th Conference on Hemoglobin Switching$20,000
R13 · FY2010 · DK · contact PI
Globin Gene Switching: Molecular Control$381,386
R01 · FY2009 · DK · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$80,092
R90 · FY2009 · HG · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$61,247
T90 · FY2009 · HG · contact PI
Stem Cell Gene Therapy for Hemoglobinopathies$2,228,313
P01 · FY2008 · HL · contact PI
Globin Gene Switching: Molecular Control$370,277
R01 · FY2008 · DK · contact PI
Development of Stem Cell Gene Therapy for Hemaglobinopathies$283,832
P01 · FY2008 · HL · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$76,995
T90 · FY2008 · HG · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$59,018
R90 · FY2008 · HG · contact PI
Stem Cell Gene Therapy for Hemoglobinopathies$2,215,800
P01 · FY2007 · HL · contact PI
Cellular Mechanisms of HB F Regulation$546,879
R01 · FY2007 · HL · contact PI
Development of Stem Cell Gene Therapy for Hemaglobinopathies$329,722
P01 · FY2007 · HL · contact PI
Globin Gene Switching: Molecular Control$78,000
R56 · FY2007 · DK · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$76,605
R90 · FY2007 · HG · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$62,530
T90 · FY2007 · HG · contact PI
Identification of Functional DNA Elements by HSqPCR$2,458,200
U01 · FY2006 · HG · contact PI
Stem Cell Gene Therapy for Hemoglobinopathies$2,223,676
P01 · FY2006 · HL · contact PI
Molecular Control of Globin Gene Switching$599,134
R37 · FY2006 · DK · contact PI
Cellular Mechanisms of HB F Regulation$550,597
R01 · FY2006 · HL · contact PI
Stem Cell Gene Therapy for Hemaglobinopatathies$316,985
P01 · FY2006 · HL · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$78,201
R90 · FY2006 · HG · contact PI
UW/FHCRC TRAINING IN HEMOGLOBINPATHIES, GENOMICS AND PROTEOMICS$64,302
T90 · FY2006 · HG · contact PI
Conference on Hemoglobin Switching$20,000
R13 · FY2006 · HL · contact PI
Identification of Functional DNA Elements by HSqPCR$2,458,204
U01 · FY2005 · HG
The UW/FHCRC Program of Excellence in Gene Therapy$2,348,469
U01 · FY2005 · HL
Stem Cell Gene Therapy for Hemoglobinopathies$2,214,612
P01 · FY2005 · HL
Molecular Control of Globin Gene Switching$596,578
R37 · FY2005 · DK
Cellular Mechanisms of HB F Regulation$551,401
R01 · FY2005 · HL
Core--Clinical$445,248
U01 · FY2005 · HL
Stem Cell Gene Therapy for Hemaglobinopatathies$309,167
P01 · FY2005 · HL
Administrative Core$146,888
U01 · FY2005 · HL
Gene Therapy for BETA ZERO Thalassemia$83,708
U01 · FY2005 · HL
Identification of Functional DNA Elements by HSqPCR$28,612
U01 · FY2005 · HG
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY$2,643,475
U01 · FY2004 · HL
Stem Cell Gene Therapy for Hemoglobinopathies$2,189,553
P01 · FY2004 · HL
Identification of Functional DNA Elements by HSqPCR$2,157,271
U01 · FY2004 · HG
MOLECULAR BIOLOGY OF HEMOPOIETIC STEM CELLS$1,051,960
P01 · FY2004 · DK
Molecular Control of Globin Gene Switching$580,094
R37 · FY2004 · DK
Cellular Mechanisms of HB F Regulation$539,140
R01 · FY2004 · HL
Stem Cell Gene Therapy for Hemaglobinopatathies$300,526
P01 · FY2004 · HL
ADMINISTRATION$122,594
P01 · FY2004 · HL
Conference on Hemoglobin Switching$40,000
R13 · FY2004 · HL
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY$2,744,642
U01 · FY2003 · HL
Identification of Functional DNA Elements by HSqPCR$2,263,508
U01 · FY2003 · HG
STEM CELL GENE THERAPY FOR HEMOGLOBINOPATHIES$1,974,038
P01 · FY2003 · HL
MOLECULAR BIOLOGY OF HEMOPOIETIC STEM CELLS$1,051,960
P01 · FY2003 · DK
Molecular Control of Globin Gene Switching$563,969
R37 · FY2003 · DK
Cellular Mechanisms of HB F Regulation$525,461
R01 · FY2003 · HL
MOLECULAR BIOLOGY OF HEMOPOIETIC STEM CELLS$10,689
P01 · FY2003 · DK
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY$2,766,645
U01 · FY2002 · HL
STEM CELL GENE THERAPY FOR HEMOGLOBINOPATHIES$1,918,566
P01 · FY2002 · HL
MOLECULAR BIOLOGY OF HEMOPOIETIC STEM CELLS$1,051,960
P01 · FY2002 · DK
Molecular Control of Globin Gene Switching$547,541
R37 · FY2002 · DK
GENE THERAPY OF SICKLE CELL DISEASE &BETA THALASSEMIA$256,500
U01 · FY2002 · HL
Development of gamma globin based gene therapy of hemoglobinopathies$88,647
P01 · FY2002 · HL
MOLECULAR BIOLOGY OF HEMOPOIETIC STEM CELLS$69,623
P01 · FY2002 · DK
13th Conference on Hemoglobin Switching$20,000
R13 · FY2002 · DK
Conference on Hemoglobin Switching$20,000
R13 · FY2002 · HL
CORE--TRANSGENIC MICE FACILITY$0
P01 · FY2002 · DK
CORE--TRANSGENIC MICE FACILITY$0
P01 · FY2002 · DK
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY$2,640,406
U01 · FY2001 · HL
STEM CELL GENE THERAPY FOR HEMOGLOBINOPATHIES$1,864,705
P01 · FY2001 · HL
MOLECULAR BIOLOGY OF HEMOPOIETIC STEM CELLS$1,051,960
P01 · FY2001 · DK
MOLECULAR CONTROL OF GLOBIN GENE SWITCHING$487,586
R37 · FY2001 · DK
CELLULAR MECHANISMS OF HB F REGULATION$443,387
R01 · FY2001 · HL
GENE THERAPY OF SICKLE CELL DISEASE &BETA THALASSEMIA$256,500
U01 · FY2001 · HL
Development of gamma globin based gene therapy of hemoglobinopathies$88,647
P01 · FY2001 · HL
3rd CONFERENCE ON HEMATOPOIETIC STEM CELL GENE THERAPY$27,360
R13 · FY2001 · DK
CORE--TRANSGENIC MICE FACILITY$0
P01 · FY2001 · DK
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY$2,565,002
U01 · FY2000 · HL
STEM CELL GENE THERAPY FOR HEMOGLOBINOPATHIES$1,812,417
P01 · FY2000 · HL
MOLECULAR BIOLOGY OF HEMOPOIETIC STEM CELLS$1,064,959
P01 · FY2000 · DK
MOLECULAR CONTROL OF GLOBIN GENE SWITCHING$474,046
R37 · FY2000 · DK
CELLULAR MECHANISMS OF HB F REGULATION$444,263
R01 · FY2000 · HL
GENE THERAPY OF SICKLE CELL DISEASE &BETA THALASSEMIA$256,500
U01 · FY2000 · HL
Development of gamma globin based gene therapy of hemoglobinopathies$223,395
P01 · FY2000 · HL
12TH CONFERENCE ON HEMOGLOBIN SWITCHING$45,000
R13 · FY2000 · DK